Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats
Antonio Abel Lozano-Pérez,1 Alba Rodriguez-Nogales,2 Víctor Ortiz-Cullera,1 Francesca Algieri,2 José Garrido-Mesa,2 Pedro Zorrilla,2 M Elena Rodriguez-Cabezas,2 Natividad Garrido-Mesa,2 M Pilar Utrilla,2 Laura De Matteis,3 Jesús Martínez de&...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c740464650d5462e88d36d4dc3909591 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c740464650d5462e88d36d4dc3909591 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c740464650d5462e88d36d4dc39095912021-12-02T00:09:56ZSilk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats1178-2013https://doaj.org/article/c740464650d5462e88d36d4dc39095912014-09-01T00:00:00Zhttp://www.dovepress.com/silk-fibroin-nanoparticles-constitute-anbspvector-for-controlled-relea-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013 Antonio Abel Lozano-Pérez,1 Alba Rodriguez-Nogales,2 Víctor Ortiz-Cullera,1 Francesca Algieri,2 José Garrido-Mesa,2 Pedro Zorrilla,2 M Elena Rodriguez-Cabezas,2 Natividad Garrido-Mesa,2 M Pilar Utrilla,2 Laura De Matteis,3 Jesús Martínez de la Fuente,3 José Luis Cenis,1 Julio Gálvez2 1Instituto Murciano de Investigación y Desarrollo Agrario y Alimentario, Murcia, Spain; 2Centro de Investigaciones Biomédicas en Red – Enfermedades Hepáticas y Digestivas, Department of Pharmacology, ibs Granada, Center for Biomedical Research, University of Granada, Granada, Spain; 3Instituto de Nanociencia de Aragón, Universidad de Zaragoza, Zaragoza, Spain Purpose: We aimed to evaluate the intestinal anti-inflammatory properties of silk fibroin nanoparticles, around 100 nm in size, when loaded with the stilbene compound resveratrol, in an experimental model of rat colitis. Methods: Nanoparticles were loaded with resveratrol by adsorption. The biological effects of the resveratrol-loaded nanoparticles were tested both in vitro, in a cell culture of RAW 264.7 cells (mouse macrophages), and in vivo, in the trinitrobenzenesulfonic acid model of rat colitis, when administered intracolonically.Results: The resveratrol liberation in 1× phosphate-buffered saline (PBS; pH 7.4) was characterized by fast liberation, reaching the solubility limit in 3 hours, which was maintained over a period of 80 hours. The in vitro assays revealed immunomodulatory properties exerted by these resveratrol-loaded nanoparticles since they promoted macrophage activity in basal conditions and inhibited this activity when stimulated with lipopolysaccharide. The in vivo experiments showed that after evaluation of the macroscopic symptoms, inflammatory markers, and intestinal barrier function, the fibroin nanoparticles loaded with resveratrol had a better effect than the single treatments, being similar to that produced by the glucocorticoid dexamethasone. Conclusion: Silk fibroin nanoparticles constitute an attractive strategy for the controlled release of resveratrol, showing immunomodulatory properties and intestinal anti-inflammatory effects. Keywords: immunomodulatory, cytokines, TNBS rat colitis, RAW 264.7 macrophage cells, antioxidantLozano-Pérez AARodriguez-Nogales AOrtiz-Cullera VAlgieri FGarrido-Mesa JZorrilla PRodriguez-Cabezas MEGarrido-Mesa NUtrilla MPDe Matteis Lde la Fuente JMCenis JLGálvez JDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 4507-4520 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Lozano-Pérez AA Rodriguez-Nogales A Ortiz-Cullera V Algieri F Garrido-Mesa J Zorrilla P Rodriguez-Cabezas ME Garrido-Mesa N Utrilla MP De Matteis L de la Fuente JM Cenis JL Gálvez J Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats |
| description |
Antonio Abel Lozano-Pérez,1 Alba Rodriguez-Nogales,2 Víctor Ortiz-Cullera,1 Francesca Algieri,2 José Garrido-Mesa,2 Pedro Zorrilla,2 M Elena Rodriguez-Cabezas,2 Natividad Garrido-Mesa,2 M Pilar Utrilla,2 Laura De Matteis,3 Jesús Martínez de la Fuente,3 José Luis Cenis,1 Julio Gálvez2 1Instituto Murciano de Investigación y Desarrollo Agrario y Alimentario, Murcia, Spain; 2Centro de Investigaciones Biomédicas en Red – Enfermedades Hepáticas y Digestivas, Department of Pharmacology, ibs Granada, Center for Biomedical Research, University of Granada, Granada, Spain; 3Instituto de Nanociencia de Aragón, Universidad de Zaragoza, Zaragoza, Spain Purpose: We aimed to evaluate the intestinal anti-inflammatory properties of silk fibroin nanoparticles, around 100 nm in size, when loaded with the stilbene compound resveratrol, in an experimental model of rat colitis. Methods: Nanoparticles were loaded with resveratrol by adsorption. The biological effects of the resveratrol-loaded nanoparticles were tested both in vitro, in a cell culture of RAW 264.7 cells (mouse macrophages), and in vivo, in the trinitrobenzenesulfonic acid model of rat colitis, when administered intracolonically.Results: The resveratrol liberation in 1× phosphate-buffered saline (PBS; pH 7.4) was characterized by fast liberation, reaching the solubility limit in 3 hours, which was maintained over a period of 80 hours. The in vitro assays revealed immunomodulatory properties exerted by these resveratrol-loaded nanoparticles since they promoted macrophage activity in basal conditions and inhibited this activity when stimulated with lipopolysaccharide. The in vivo experiments showed that after evaluation of the macroscopic symptoms, inflammatory markers, and intestinal barrier function, the fibroin nanoparticles loaded with resveratrol had a better effect than the single treatments, being similar to that produced by the glucocorticoid dexamethasone. Conclusion: Silk fibroin nanoparticles constitute an attractive strategy for the controlled release of resveratrol, showing immunomodulatory properties and intestinal anti-inflammatory effects. Keywords: immunomodulatory, cytokines, TNBS rat colitis, RAW 264.7 macrophage cells, antioxidant |
| format |
article |
| author |
Lozano-Pérez AA Rodriguez-Nogales A Ortiz-Cullera V Algieri F Garrido-Mesa J Zorrilla P Rodriguez-Cabezas ME Garrido-Mesa N Utrilla MP De Matteis L de la Fuente JM Cenis JL Gálvez J |
| author_facet |
Lozano-Pérez AA Rodriguez-Nogales A Ortiz-Cullera V Algieri F Garrido-Mesa J Zorrilla P Rodriguez-Cabezas ME Garrido-Mesa N Utrilla MP De Matteis L de la Fuente JM Cenis JL Gálvez J |
| author_sort |
Lozano-Pérez AA |
| title |
Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats |
| title_short |
Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats |
| title_full |
Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats |
| title_fullStr |
Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats |
| title_full_unstemmed |
Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats |
| title_sort |
silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats |
| publisher |
Dove Medical Press |
| publishDate |
2014 |
| url |
https://doaj.org/article/c740464650d5462e88d36d4dc3909591 |
| work_keys_str_mv |
AT lozanoperezaa silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT rodrigueznogalesa silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT ortizcullerav silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT algierif silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT garridomesaj silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT zorrillap silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT rodriguezcabezasme silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT garridomesan silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT utrillamp silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT dematteisl silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT delafuentejm silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT cenisjl silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats AT galvezj silkfibroinnanoparticlesconstituteanbspvectorforcontrolledreleaseofresveratrolinnbspannbspexperimentalmodelofinflammatorybowelnbspdiseaseinrats |
| _version_ |
1718403953407819776 |